Experiment 1015353

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODEINFRARED SPECTRUM REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION FOLLOWING BIOLOGICAL CONVERSION BYUV SPECTRUM GIVEN FORPMR SPECTRUM REPORTED

Compounds isolated

BRUCEANTIN-4'-5'-EPOXIDE

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeIP
OrganismStreptomyces griseus (STREPTOMYCETACEAE)
CitationCHIEN,MM: ROSAZZA,JP:. (1981). MICROBIAL TRANSFORMATIONS OF NATURAL ANTITUMOUR AGENTS. PART 15. METABOLISM OF BRUCEANTIN BY STREPTOMYCES GRISEUS.. 1981()
Amount utilized
Compound isolated
DiseaseDAILY DOSING ON DAYS 1-9
Dose amount0.12 MG
Number8
Qualitative resultINACTIVE
AnimalMOUSE
Per unitKG
Dose expressionDOSE